Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Chan

Showing results (281-290 of 407) with videos related to

Pageof 41
Sort By:
British Journal of Cancer|January 22, 2009
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancersJ Ying, F F Poon, J Yu, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II studySimon C H Yu, Edwin P Hui, John Wong, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Clinical Chemistry|April 24, 2003
Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypesTerence C W Poon, Tai-Tung Yip, Anthony T C Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaB B Y Ma, M K M Kam, S F Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
Nasopharyngeal cancers: which method should be used to measure these irregularly shaped tumors on cross-sectional imaging?Ann D King, Benny Zee, Edmund H Y Yuen, et al.
Molecular Cancer Research : MCR|June 9, 2012
A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomasYingduan Cheng, Pei Liang, Hua Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinomaSing-fai Leung, Benny Zee, Brigette B Ma, et al.
Pageof 41

Showing results (281-290 of 407) with videos related to

Sort By:
Pageof 41
British Journal of Cancer|January 22, 2009
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancersJ Ying, F F Poon, J Yu, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II studySimon C H Yu, Edwin P Hui, John Wong, et al.
Investigational New Drugs|November 13, 2012
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
Clinical Chemistry|April 24, 2003
Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypesTerence C W Poon, Tai-Tung Yip, Anthony T C Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaB B Y Ma, M K M Kam, S F Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
Nasopharyngeal cancers: which method should be used to measure these irregularly shaped tumors on cross-sectional imaging?Ann D King, Benny Zee, Edmund H Y Yuen, et al.
Molecular Cancer Research : MCR|June 9, 2012
A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomasYingduan Cheng, Pei Liang, Hua Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinomaSing-fai Leung, Benny Zee, Brigette B Ma, et al.
Pageof 41